Tekla Healthcare Investors (HQH) Key Ratios
$21.64
As on 17-Sep-2026 16:00EDT
Market cap
$1,286 Mln
Revenue (TTM)
$19 Mln
P/E Ratio
5
P/B Ratio
1.1
Div. Yield
10.1 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | 211.67 | 826.84 | 36.07 | -16.30 |
| EBIT | -- | -- | -- | -- | -- |
| Net Profit | -- | 103.46 | -46.68 | 35.86 | -16.38 |
| EPS | -- | 99.18 | -47.80 | 34.60 | -20.01 |
| Book Value | -- | -- | 1.06 | 1.03 | -3.65 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Sep-25 | Sep-24 | Sep-23 |
| EBIT-Margin
| 96.93 | 98.91 | -- | -- | 96.93 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| 11.28 | 5.83 | 9.16 | 18.58 | 6.10 |
| Return on Capital
| 11.27 | 5.84 | 9.16 | 18.58 | 6.07 |
| Return on Assets
| 11.25 | 5.83 | 9.14 | 18.56 | 6.06 |
| Debt to Equity (x)
| -- | -- | -- | -- | -- |
Profitability
ROCE
9.16
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
9.16
|
18.58
|
6.07
|
-18.56
|
13.96
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
9.16
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
9.16
|
18.58
|
6.10
|
-18.73
|
14.03
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
9.14
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
9.14
|
18.56
|
6.06
|
-18.51
|
13.93
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
--
|
96.93
|
101.02
|
98.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
98.80
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
98.80
|
1,717.36
|
96.93
|
101.02
|
98.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
8.27
--
Year on year growth in net sales
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
8.27
|
-0.81
|
1.30
|
-2.22
|
-0.35
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
--
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
--
|
129.00
|
-225.17
|
-35.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-46.68
--
Year on year growth in profit after tax
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
-46.68
|
228.30
|
129.00
|
-225.17
|
-35.67
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
-0.48
--
Year on year growth in earnings per share
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
-0.48
|
2.03
|
1.28
|
-2.20
|
-0.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
--
|
--
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
--
|
--
|
0.01
|
0.01
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
2.15
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
2.15
|
0.43
|
34.51
|
4.40
|
0.79
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
--
|
34.51
|
-0.87
|
-0.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
--
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
2.54
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
2.54
|
4.60
|
11.79
|
-1.49
|
2.58
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.09
--
Sales / Average Total Assets
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
0.09
|
0.01
|
0.06
|
-0.18
|
0.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
5.55
--
Average Debtors / Sales * 365
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
5.55
|
124.64
|
30.55
|
-6.57
|
9.73
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
0.01
|
857.48
|
1,209.69
|
735.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
10.26
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
10.26
|
5.40
|
13.65
|
-4.21
|
7.49
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.92
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
0.92
|
0.94
|
0.83
|
0.89
|
1.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
10.26
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Sep-25
|
Sep-24
|
Sep-23
|
Sep-22
|
Sep-21
|
|---|---|---|---|---|---|
|
Tekla Healthcare Investors (HQH)
|
10.26
|
--
|
13.07
|
-4.08
|
7.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|